DalCor Pharmaceuticals

Company Information

DalCor Pharmaceuticals was founded on January 2015. The company is based in Montréal. The number of employees in DalCor Pharmaceuticals is less than 50. Dalcor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits

♥ If you are the founder or part of the founding team, please tell the world your story ♥

Funding & investors

DalCor Pharmaceuticals has received 2 rounds of venture funding. The total funding amount is around $150M.

• Sanderling Ventures (Micro vc)
• CTI Life Sciences Fund (Venture capital)
• André Desmarais (Angel)
• Caisse de Depot et Placement du Quebec (Government office)
• Fonds de solidarité FTQ (Venture capital)

Similar Companies [beta]

• Gritstone oncology
• Citizen health
• Genomenon
• Maze therapeutics
• Coherus biosciences
• Carmot therapeutics
• More...

Venture Categories

• Biotechnology
• Health Care
• Wellness

Active Venture Investors

• Active Investors in Biotechnology
• Active Investors in Health Care
• Active Investors in Wellness

Venture Competitors

• Best Funded Biotechnology Startups
• Best Funded Health Care Startups
• Best Funded Wellness Startups

News

• news on Google
• news on VentureBeat
• news on YouTube

DalCor Pharmaceuticals - Blog

• Hello world!


Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Share: